Rasagiline 13C3 mesylate racemic Catalog No.:M11336-2 5-dihydro-1H-imidazol-2-amine4

5-dihydro-1H-imidazol-2-amine4

5-trien-7-yl]methyl}amino)propyl]-7

is a novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity

is a thiophene thiourea derivative with molecule weight 260

PubMed Central PMCID: PMC1906333

Rasagiline 13C3 mesylate racemic Catalog No.:M11336-2 5-dihydro-1H-imidazol-2-amine4Rasagiline 13C3 mesylate racemic is the deuterium labeled Rasagiline mesylate racemic. Rasagiline mesylate racemic is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor. Product information CAS Number: 1216757 55 9 Molecular Weight: 270. 32 Formula: C13H17NO3S Chemical Name: N [(1,2,3 C)prop 2 yn 1 yl] 2,3 dihydro 1H inden 1 amine; methanesulfonic acid Smiles: CS(O)(=O)=O.[13CH]#[13C][13CH2]NC1CCC2=CC=CC=C21